Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Letter to the Editor

Value of Patient Population Selection and Lyme Borreliosis Tests

Alexis Lacout, Pierre Yves Marcy, Marie Mas, Christian Perronne, Michel Franck
Brad Fenwick, Editor
Alexis Lacout
aCentre de Diagnostic–ELSAN, Aurillac, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Yves Marcy
bPolyclinique Les Fleurs–ELSAN Service Imagerie Médicale, Ollioules, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie Mas
cClinique Convert, Service des Urgences, Bourg en Bresse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Perronne
dInfectious Diseases Unit, University Hospital Raymond Poincaré, APHP Versailles Saint Quentin University, Garches, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Franck
eADNucleis, Grézieu la Varenne, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brad Fenwick
University of Tennessee at Knoxville
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.01517-18
  • Article
  • Info & Metrics
  • PDF
Loading

LETTER

Regarding the paper entitled “Serological diagnostics of Lyme borreliosis: comparison of universal and Borrelia species-specific tests based on whole-cell and recombinant antigens” by P. Kodym et al. (1), we congratulate the authors and wish to add further comments.

It is worth noting that neuroborreliosis can present with meningoradiculitis.

Performing the cerebrospinal fluid (CSF) analysis is, in our opinion, particularly relevant in patients presenting with a clinical symptomatology suggestive of central neurological involvement, such as acute meningoradiculitis. However, some patients might exclusively suffer from peripheral neurological impairment, namely, in the chronic forms, the so-called “persistent polymorphic symptomatology after tick-bite” (PPSTB) or “posttreatment Lyme disease syndrome” (PTLDS). Such patients often report clinical signs, including paresthesia, dysesthesia, and neuropathic pain. This clinical syndrome has been well described by Rebman et al. (2) and, unfortunately, was not considered in the article by Kodym et al.

In the case of persistent borrelia disease, the neurological involvement form is most often peripheral; this explains the normality of the CSF sample.

Since a final diagnosis cannot be made by lumbar puncture (3), clinical examination, the exclusion of other diagnoses, and additional biological tests and examinations (an electromyogram can be useful) are mandatory. In such a chronic case, serological tests might lack sensitivity, and this has been stated by published articles and meta-analyses (4–6). The chronicity of the disease may be partly explained by the host’s autoimmunity and also by the particular organization of Borrelia into persisters: the biofilms and transformations into resistant “round bodies” (7–9). This hypothesis is controversial, mainly because the studies were made in vitro. These persisters show resistance to many antibiotic treatments that are usually active against Borrelia species. The immune evasion of pathogenic organisms and immunosuppression induced by Borrelia (marked by a deficiency in the TH2 response and the lack of a humoral response) may also explain both the reality of a chronic form and the false-negative serological results (10).

Interestingly, the clinical symptomatology of patients may not correlate with the biological diagnosis (serology/PCR). First, patients with positive results may experience little or no improvement with any antibiotic therapy. Second, in some patients with negative biologic results, clinical improvements and setbacks corresponding strictly to the administration and interruption of antibiotics may resemble the chronic persistence of a Borrelia event (11). The search by PCR for Borrelia and other coinfection agents may be helpful and can be performed in various media (2). Therefore, because of these strong biological limitations, Blanc et al. (12) and the recent High Authority of Health (Haute Autorité de Santé [HAS]) 2018 French report advocate useful and valuable antibiotic testing (for 1 month) when the clinical symptomatology is suggestive of Lyme diagnosis (2) whatever the results of biologic testing. Also, it is interesting to note that some migrant erythema cases could be caused by pathogens other than Borrelia (13).

Moreover, there is evidence that there is healthy carriage (14–16). Steere et al. concluded that the asymptomatic infection is, in fact, uncommon. However, owing to some difficulties in finding Borrelia in vivo by current microbiology techniques, it is difficult to be certain about the prevalence of such healthy carriers. The latter could be more numerous than expected because of changes in their lifestyles (hiking in the countryside, along trails, etc.). The selection of the control population reported in the article by Kodym et al. is therefore debatable. On the one hand, for all of the reasons mentioned above, it is obvious that there is no reliable random reference sample in the general population. On the other hand, the “sick patients” sample does not appear to be reliable in this article because this might exclude a too-large population of patients (including patients presenting with a chronic form) who often present with negative serological tests. Therefore, in our opinion, it seems impossible to reliably calculate any sensitivity and specificity for the biological tests for Lyme borreliosis.

ACKNOWLEDGMENTS

No external funding was received.

There were no conflicts of interest.

FOOTNOTES

  • For the author reply, see https://doi.org/10.1128/JCM.01793-18.

  • Copyright © 2019 American Society for Microbiology.

All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Kodym P,
    2. Kurzová Z,
    3. Berenová D,
    4. Pícha D,
    5. Smíšková D,
    6. Moravcová L,
    7. Malý M
    . 2018. Serological diagnostics of Lyme borreliosis: comparison of universal and Borrelia species-specific tests based on whole-cell and recombinant antigens. J Clin Microbiol pii:JCM.00601-18. doi:10.1128/JCM.00601-18.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Rebman AW,
    2. Bechtold KT,
    3. Yang T,
    4. Mihm EA,
    5. Soloski MJ,
    6. Novak CB,
    7. Aucott JN
    . 2017. The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with posttreatment Lyme disease syndrome. Front Med (Lausanne) 4:224. doi:10.3389/fmed.2017.00224.
    OpenUrlCrossRef
  3. 3.↵
    1. Horowitz RI,
    2. Lacout A,
    3. Marcy PY,
    4. Perronne C
    . 2018. To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis. Clin Microbiol Infect 24:210. doi:10.1016/j.cmi.2017.09.015.
    OpenUrlCrossRef
  4. 4.↵
    1. Leeflang MM,
    2. Ang CW,
    3. Berkhout J,
    4. Bijlmer HA,
    5. Van Bortel W,
    6. Brandenburg AH,
    7. Van Burgel ND,
    8. Van Dam AP,
    9. Dessau RB,
    10. Fingerle V,
    11. Hovius JW,
    12. Jaulhac B,
    13. Meijer B,
    14. Van Pelt W,
    15. Schellekens JF,
    16. Spijker R,
    17. Stelma FF,
    18. Stanek G,
    19. Verduyn-Lunel F,
    20. Zeller H,
    21. Sprong H
    . 2016. The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis. BMC Infect Dis 16:140. doi:10.1186/s12879-016-1468-4.
    OpenUrlCrossRef
  5. 5.↵
    1. Cook MJ,
    2. Puri BK
    . 2016. Commercial test kits for detection of Lyme borreliosis: a meta-analysis of test accuracy. Int J Gen Med 9:427–440. doi:10.2147/IJGM.S122313.
    OpenUrlCrossRef
  6. 6.↵
    1. Lawrence C,
    2. Lipton RB,
    3. Lowy FD,
    4. Coyle PK
    . 1995. Seronegative chronic relapsing neuroborreliosis. Eur Neurol 35:113–117. doi:10.1159/000117104.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Brorson O,
    2. Brorson SH
    . 1997. Transformation of cystic forms of Borrelia burgdorferi to normal, mobile spirochetes. Infection 25:240–246. doi:10.1007/BF01713153.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Miklossy J,
    2. Kasas S,
    3. Zurn AD,
    4. McCall S,
    5. Yu S,
    6. McGeer PL
    . 2008. Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. J Neuroinflamm 5:40. doi:10.1186/1742-2094-5-40.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Sapi E,
    2. Balasubramanian K,
    3. Poruri A,
    4. Maghsoudlou JS,
    5. Socarras KM,
    6. Timmaraju AV,
    7. Filush KR,
    8. Gupta K,
    9. Shaikh S,
    10. Theophilus PA,
    11. Luecke DF,
    12. MacDonald A,
    13. Zelger B
    . 2016. Evidence of in vivo existence of Borrelia biofilm in borrelial lymphocytomas. Eur J Microbiol Immunol 6:9–24. doi:10.1556/1886.2015.00049.
    OpenUrlCrossRef
  10. 10.↵
    1. Elsner RA,
    2. Hastey CJ,
    3. Olsen KJ,
    4. Baumgarth N
    . 2015. Suppression of long-lived humoral immunity following Borrelia burgdorferi infection. PLoS Pathog 11:e1004976. doi:10.1371/journal.ppat.1004976.
    OpenUrlCrossRef
  11. 11.↵
    1. Lacout A,
    2. El Hajjam M,
    3. Marcy P-Y,
    4. Perronne C
    . 2018. The persistent Lyme disease: “true chronic Lyme disease” rather than “post-treatment Lyme disease syndrome.” J Glob Infect Dis 10:170–171. doi:10.4103/jgid.jgid_152_17.
    OpenUrlCrossRef
  12. 12.↵
    1. Blanc F,
    2. Jaulhac B,
    3. Fleury M,
    4. de Seze J,
    5. de Martino SJ,
    6. Remy V,
    7. Blaison G,
    8. Hansmann Y,
    9. Christmann D,
    10. Tranchant C
    . 2007. Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. Neurology 69:953–958. doi:10.1212/01.wnl.0000269672.17807.e0.
    OpenUrlCrossRef
  13. 13.↵
    1. Kannangara DW,
    2. Patel P
    . 28 November 2018. Report of non-Lyme, erythema migrans rashes from New Jersey with a review of possible role of tick salivary toxins. Vector-Borne Zoonotic Dis doi:10.1089/vbz.2018.2278.
    OpenUrlCrossRef
  14. 14.↵
    1. Niścigorska J,
    2. Skotarczak B,
    3. Wodecka B
    . 2003. Borrelia burgdorferi infection among forestry workers assessed with an immunoenzymatic method (ELISA), PCR, and correlated with the clinical state of the patients. Ann Agric Environ Med 10:15–19.
    OpenUrlPubMed
  15. 15.↵
    1. Steere AC,
    2. Sikand VK,
    3. Schoen RT,
    4. Nowakowski J
    . 2003. Asymptomatic infection with Borrelia burgdorferi. Clin Infect Dis 37:528–532. doi:10.1086/376914.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Kean IR,
    2. Irvine KL
    . 2013. Lyme disease: aetiopathogenesis, factors for disease development and control. Inflammopharmacology 21:101–111. doi:10.1007/s10787-012-0156-2.
    OpenUrlCrossRef
PreviousNext
Back to top
Download PDF
Citation Tools
Value of Patient Population Selection and Lyme Borreliosis Tests
Alexis Lacout, Pierre Yves Marcy, Marie Mas, Christian Perronne, Michel Franck
Journal of Clinical Microbiology Feb 2019, 57 (3) e01517-18; DOI: 10.1128/JCM.01517-18

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Value of Patient Population Selection and Lyme Borreliosis Tests
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Value of Patient Population Selection and Lyme Borreliosis Tests
Alexis Lacout, Pierre Yves Marcy, Marie Mas, Christian Perronne, Michel Franck
Journal of Clinical Microbiology Feb 2019, 57 (3) e01517-18; DOI: 10.1128/JCM.01517-18
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • LETTER
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Info & Metrics
  • PDF

KEYWORDS

Borrelia
Lyme disease
PCR
serology
population

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X